Piramal Pharma Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹2,269.92 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.51 per cent from ₹2,751.77 crore. This corresponds to a year-on-year *(YoY) growth of 17.39 per cent.
Operating Profit
Operating Profit stands at ₹195.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.45 per cent from ₹284.74 crore. This corresponds to a year-on-year *(YoY) growth of 82.94 per cent.
PBDT
PBDT stands at ₹216.09 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.33 per cent from ₹261.38 crore. This corresponds to a year-on-year *(YoY) growth of 82.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-7.46 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 117.35 per cent from ₹43.00 crore. This corresponds to a year-on-year *(YoY) growth of 90.56 per cent.
Net Profit
Net Profit stands at ₹-69.39 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 685.84 per cent from ₹-8.83 crore. This represents a 15.07 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Piramal Pharma Ltd News
Piramal Pharma Ltd Earnings
- YOY
- QOQ
Piramal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Piramal Pharma Ltd Research Reports
Piramal Pharma Ltd Financial Reports
Piramal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Piramal Pharma | -1.36% | 4.30% | 17.89% | 19.07% | 33.85% | 10.79% |
| Wockhardt | 2.91% | -0.43% | 1.94% | 15.03% | 38.54% | 30.20% |
| Neuland Labs. | -1.14% | -1.60% | 25.44% | 39.14% | 74.27% | 72.00% |
| Rubicon Research | -2.60% | -4.06% | 13.57% | 82.87% | 122.64% | 174.96% |
| Acutaas Chemical | -1.50% | -1.01% | -2.72% | 8.51% | 47.41% | 122.64% |
| Pfizer | 1.10% | 3.04% | 7.74% | 5.97% | -2.19% | -9.16% |
| Granules India | 2.06% | -0.39% | 2.97% | 13.23% | 43.17% | 86.13% |
Company Info
Company Information
Chairperson / Executive Director : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Independent Non Exe. Director : Nathalie Leitch
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Independent Non Exe. Director : Vibha Paul Rishi
Independent Non Exe. Director : AMIT SONI
Company Sec. & Compli. Officer : Maneesh Sharma